Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123354152 | 12335415 | 2 | F | 20160818 | 20160504 | 20160825 | EXP | CA-AMGEN-CANSP2016055292 | AMGEN | 58.00 | YR | A | F | Y | 0.00000 | 20160825 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123354152 | 12335415 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 123354152 | 12335415 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 123354152 | 12335415 | 3 | SS | HYDROXYCHLOROQUINE SULPHATE | HYDROXYCHLOROQUINE | 1 | Unknown | UNK | 0 | ||||||||||
| 123354152 | 12335415 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 123354152 | 12335415 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 123354152 | 12335415 | 6 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 123354152 | 12335415 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 123354152 | 12335415 | 8 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | UNK | 0 | TABLET | ||||||||||
| 123354152 | 12335415 | 9 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 123354152 | 12335415 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | TABLET | ||||||||||
| 123354152 | 12335415 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | 0 | CAPSULE | ||||||||||
| 123354152 | 12335415 | 12 | C | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123354152 | 12335415 | 1 | Rheumatoid arthritis |
| 123354152 | 12335415 | 2 | Rheumatoid arthritis |
| 123354152 | 12335415 | 3 | Rheumatoid arthritis |
| 123354152 | 12335415 | 4 | Rheumatoid arthritis |
| 123354152 | 12335415 | 6 | Product used for unknown indication |
| 123354152 | 12335415 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123354152 | 12335415 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123354152 | 12335415 | Arthralgia | |
| 123354152 | 12335415 | Condition aggravated | |
| 123354152 | 12335415 | Drug ineffective | |
| 123354152 | 12335415 | Injection site bruising | |
| 123354152 | 12335415 | Injection site erythema | |
| 123354152 | 12335415 | Injection site pruritus | |
| 123354152 | 12335415 | Injection site rash | |
| 123354152 | 12335415 | Injection site reaction | |
| 123354152 | 12335415 | Injection site swelling | |
| 123354152 | 12335415 | Joint swelling | |
| 123354152 | 12335415 | Nasopharyngitis | |
| 123354152 | 12335415 | Rheumatoid arthritis | |
| 123354152 | 12335415 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |